Gene: HRH2
Official Full Name: histamine receptor H2provided by HGNC
Gene Summary: Histamine is a ubiquitous messenger molecule released from mast cells, enterochromaffin-like cells, and neurons. Its various actions are mediated by histamine receptors H1, H2, H3 and H4. Histamine receptor H2 belongs to the family 1 of G protein-coupled receptors. It is an integral membrane protein and stimulates gastric acid secretion. It also regulates gastrointestinal motility and intestinal secretion and is thought to be involved in regulating cell growth and differentiation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08134 | HRH2 Knockout cell line (A549) | Human | HRH2 | 1:3~1:4 | Negative | Online Inquiry |
HRH2 Gene Knockout Cell Lines are engineered cellular models specifically designed to study the functional roles of the Histamine Receptor H2 (HRH2) gene in various biological processes. These knockout cell lines are characterized by the targeted disruption of the HRH2 gene, which encodes for a receptor involved in mediating histamine signaling pathways, influencing immune response, gastric acid secretion, and neuroinflammatory processes.
The primary function of the HRH2 gene knockout cell lines is to enable researchers to elucidate the physiological and pathological consequences of HRH2 signaling or its absence. Mechanistically, the disruption of this gene alters cellular responses to histamine, providing insights into how its modulation affects downstream signaling pathways like cAMP production and calcium signaling. Identifying these effects is crucial for understanding the receptor's role in disease states, including allergies, gastric disorders, and neurological conditions.
The scientific importance of HRH2 gene knockout cell lines is underscored by their versatility in both research and clinical applications. In a laboratory setting, these models serve as invaluable tools for drug discovery, allowing researchers to test the efficacy of potential therapeutics that target the HRH2 pathway. Furthermore, the insights gained from these cell lines can drive innovations in the development of targeted treatments for conditions associated with dysregulated histamine signaling.
What sets our HRH2 gene knockout cell lines apart from traditional models is not only their precision in gene editing but also the quality of the cell lines, which are validated for consistent performance and reproducibility. Unlike alternative methods that may introduce variable background effects, our knockout lines offer a clean genetic slate that enhances the reliability of experimental outcomes.
For researchers and clinicians alike, the value of HRH2 gene knockout cell lines lies in their capacity to accelerate discoveries in histamine-related research and to foster the development of next-generation therapeutic strategies. They represent a critical resource for advancing our understanding of complex biological systems influenced by histamine signaling.
With expertise in the field of genetic engineering and a commitment to delivering high-quality biological products, our company stands at the forefront of innovative research solutions, empowering scientists to translate their findings into meaningful health advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.